The years of research and investigation into Cannabis breeding and the multitude of applications of the Cannabis extractions has been the focus of mine, Scott Blakey (B.Sc. Melbourne University); an Australian living in Europe since 1989.

After meeting up and establishing a reliable and trustworthy bond with my partner, Dr. Iva Hoskova, Ph. D. who is internationally well established in pharmacology-toxicoloxy, product-development and regulatory affairs, an organic partnership naturally developed. With me and my partner working on different areas of product development it is like 1+1=3, and an incredibly strong and conscientious team has been born at a pivotal moment in this World market of Cannabis and Wellness products.

With impressive skills, reliability and expertise that complimented my breeding work and genetic library of cannabis plants, the creation of the company SCIVA Corporation has emerged in 2019.

Now, well entrenched in the Czech Republic for several years, we have developed a range of end products that stand above the crowd. Firstly, these products have an edge above all others with their terpene profile. Secondly, the main emphasis is that these end products are working exceptionally well on all the case studies and for a plethora of physical issues. Thirdly, our products are GMP manufactured and under the Novel Food registration process by EFSA since 2018. Lastly, all our products are all grown from a single selected plant, harvested, dried and processed with our own chemists to an exceptionally high level, thus keeping our base extraction unique and consistent and only available from our company!

We are and plan to maintain our position as a world leader in high end Cannabis products that serve the community with a well oiled working model. We are a producing company of high end, high quality base products that can be used in the entire range of Cannabis products available on the market. Diverse base products such as water soluble CBD, CBD and CBG isolate, wide spectrum whole plant extraction based on a single selected hemp plant, distillate for E-cigarettes and for vaporizing technology fully winterized and all with certifications of contents both for EU and USA retail market.

Sciva Corporation has found its niche in this emerging Cannabis market and intends to gather momentum in the world of base product supply of Cannabis related products, uniquely founded on well established genetic material, all GMP manufactured and under the Novel Food registration process by EFSA: